Date: Thursday, March 20
Time: 3:00 – 4:00 p.m. (EDT)

This WuXi AppTec event is complementary and open to life science professionals globally.
For additional information and registration, please click here.

WHAT WILL BE COVERED

  • Overview of 361/351 products, including regulations, development considerations, and challenges.
  • Driving product quality through QbD comprising risk mitigation and testing strategies – from preclinical to commercial programs.
  • New technologies for assessment  of viral contaminants to donor cell lines and raw materials.
  • Analysis of extractables/leachables for particulates and product purity, including product stability.

SPEAKERS/Q&A PANEL

Alan Moore      Vice President – Cell Manufacturing • Wuxi AppTec

Healther Malicki      Director – Virology Technology Development • Wuxi AppTec

Sandi Schaible     Director – Analytical Chemistry • Wuxi AppTec

Click here to register.

 

UPCOMING SPRING WEBINAR SERIES

APRIL | Translating Early-Stage Programs to Clinic-Ready Production – Including process scale-up considerations and applications of Corning HYPER® platform technologies

MAY | cGMP Compliance Trends and Challenges for Late-Stage Programs  Including timeline management, quality control, and rapid release of commercial-ready products

Event contact:

Sharmilee Patel • Business Development – Cell & Tissue Programs
sharmilee.patel@wuxiapptec.com
919-288-4523